Neuroimmunophilins: a novel drug therapy for the reversal of neurodegenerative disease?
Poulter
M O
MO
Department of Psychology, Neuroscience Research Institute, Carleton University, 1125 Colonel By Drive, Ottawa, Ontario, Canada K1S 5B6. michael_poulter@carleton.ca
Payne
K B
KB
Steiner
J P
JP
D000818:Animals; D002986:Clinical Trials as Topic; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009410:Nerve Degeneration / Q000188:drug therapy; D019636:Neurodegenerative Diseases / Q000188:drug therapy*; D009474:Neurons / Q000187:drug effects*
D007166:Immunosuppressive Agents